top of page

AB22 Syngeneic Model

Rincon Bio offers efficacy studies using the AB22 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Lung
Derivation:
Malignant mesothelial cells dertived fromascited of asbestos-exxposed BALB/c mice
Mutations:
CDKN2A
NCI60:
No
Weeks from stratification to termination (average):
N/A

AB22 Growth Curve

(Representative of studies performed at Rincon Bio)

Contact Rincon Bio for a growth curve and more information on the AB22 syngeneic model.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page